WCM Investment Management’s Emergent Biosolutions EBS Stock Holding History

WCM Investment Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-66,979	Closed	-$6M	–	194
2020 Q4	$6M	Buy	66,979 +1,135	+2%	+$104K	0.02%	139
2020 Q3	$6.8M	Sell	65,844 -39,417	-37%	-$4.25M	0.02%	120
2020 Q2	$8.32M	Buy	105,261 +6,165	+6%	+$459K	0.03%	81
2020 Q1	$5.73M	Buy	99,096 +8,058	+9%	+$464K	0.03%	95
2019 Q4	$4.91M	Buy	91,038 +16,264	+22%	+$882K	0.03%	110
2019 Q3	$3.91M	Sell	74,774 -4,946	-6%	-$230K	0.02%	73
2019 Q2	$3.85M	Buy	+79,720	New	+$3.82M	0.02%	66

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WCM Investment Management's EBS Position: Q1 2021 in Review

WCM Investment Management sold out of Emergent Biosolutions (EBS) in Q1 2021, closing a stake of 66,979 shares — an estimated $6M sold.

WCM Investment Management first reported a position in EBS in Q2 2019 and held it in 7 quarters. The position peaked at $8.32M in Q2 2020. 340 funds tracked by Wall St. Rank hold EBS as of Q1 2021.

WCM Investment Management reported no remaining Emergent Biosolutions position as of Q1 2021 after selling out during the quarter.
WCM Investment Management sold 66,979 Emergent Biosolutions shares in Q1 2021, an estimated $6M.
WCM Investment Management first reported a position in Emergent Biosolutions in Q2 2019 and held it in 7 quarters.
WCM Investment Management's Emergent Biosolutions position peaked at $8.32M in Q2 2020.
340 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2021.

Based on WCM Investment Management's 13F filing for Q1 2021, filed 13 May 2021.